BioSpace News Archive

Microbot Medical Inc. announced that the United States Patent and Trademark Office has issued a Notice of Allowance for patent application No. 15/592,227, which pertains to a device for reducing dialysis shunt stenosis.

Applied Genetic Technologies Corporation, Blueprint Genetics, and Foundation Fighting Blindness, announce that AGTC, a biotechnology company conducting human clinical trials of adeno-associated virus -based gene therapies for the treatment of rare diseases, will join the My Retina Tracker® Program as a new scientific collaborator to enhance development of its investigational gene therapies for inherited retinal diseases.

Q3 2020 net product revenues are estimated to be between $5.5- $5.9million, ashealthcare facilities began reopening from COVID-19 closures

AnPac Bio-Medical Science Co., Ltd. announced that in recognition of its successes in leading edge life science innovations and advancements and in support of its R&D and product commercialization efforts, AnPac Bio has obtained three grants and one rental award from various local authorities in China with a portion of the funding subject to milestone achievements.

A World’s First That Combines Innovative Technologies: Titan nanoLOCK™ Surface Technology and Navigation

Luminex Corporation announced 3rd quarter 2020 revenues of approximately $106 million, up approximately 35% over the 3rd quarter of 2019.

Decipher Prostate is the first and only genomic test recognized by eviCore for the management of prostate cancer patients after surgery

Oncolytics Biotech® Inc. announced that the Company will be participating in the BIO Investor Forum Digital, which is taking place virtually from October 13-15, 2020.

NC-iMSCs demonstrate higher potency, uniformity and consistency - significant advantages over donor derived MSCs

New Preclinical Repeat-Dose Data Support Company Plans to Evaluate Multiple Ascending Dose Levels in MONARCH, Subject to FDA Review